Transcript
Page 1: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Thrombolysis for DVTPatient Selection and

Pre Op Evaluation

Anthony J. Comerota, MD, FACS, FACC

Director, Jobst Vascular Institute

Adjunct Professor of Surgery, University of Michigan

April 8-9, 2011New York LaGuardia Marriott

COMPLETE MANAGEMENT OF VENOUS DISEASE

Page 2: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Disclosure

Anthony Comerota, M.D., FACS, FACC

I disclose the following financial relationship(s):

Speaker/Honoraria: BMS, Covidien

Page 3: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Which DVT patients benefit most by a

treatment strategy of thrombus removal?

Probably all…but for sure, patients with

iliofemoral DVT

Thrombolysis for DVT

Patient Selection

Page 4: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Why patients with iliofemoral DVT?

1. Most severe post-thrombotic morbidity

2. Highest venous pressures

3. Greatest recurrence

Thrombolysis for DVT

Patient Selection

Page 5: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Findings

• 1 month observation was best predictor of

long-term outcome (p<0.001)

• IFDVT patients had the most severe

post-thrombotic morbidity (OR 2.23; p<0.001)

Acute DVT

Outcomes After Anticoagulation Alone

Ann Int Med 2008; 149:698

Page 6: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Patient Selection

Thrombolysis for DVT

- Observational Studies -

• Decreased QOL

• 95% chronic venous disease

• 15% venous ulceration

• 15-40% venous claudication

Iliofemoral DVT Rx with anticoagulation alone

at 5 years

Delis KT et al

Ann Surg 2004;239(1):118

Akesson H

Eur J Vasc Surg 1990

Page 7: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Labropoulos N et al

Arch Surg 1997; 132:46

Hemodynamics of Venous Obstruction

Arm - Foot Pressure Gradient

- Post Thrombotic Limbs -

Location Rest Hyperemic

Iliofemoral 6.3 mmHg 8.9 mmHg

Femoral-popliteal 4.4 mmHg 7.3 mmHg

Popliteal 1.5 mmHg 3.1 mmHg

Controls 1.0 mmHg 2.7 mmHg

Page 8: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Intramuscular Pressures (mmHg)

Iliofemoral DVT

Days

Intramuscular

Pressure

(mmHg)

Anterior & Deep Posterior Compartments (Mean)

Qvarfordt P et al

Ann Surg 1983;197:450

• 12 Patients with iliofemoral DVT

• Venous thrombectomy

• Intramuscular pressures (wick)(Surrogate for venous pressure)

Pre-Op(Mean)

Post-Op(Mean)

Reduction of pressure to normal

after thrombus removal

Page 9: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Risk of Recurrence

1,149 Symptomatic DVT Rx’ed

with Anticoagulation

Iliofemoral DVT

Overall recurrence @ 3 mos – 5.1%

Femoral vein thrombosis – 5.3%

Iliofemoral DVT – 11.8%

Douketis JD et al

Am J Med 2001;110:515

Results

Risk for Recurrence

Factor Odds Ratio

Iliofemoral DVT 2.4

Cancer 2.6

Page 10: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Before… Venous thrombectomy

Catheter-directed thrombolysis

Thrombolysis for DVT

Pre Op Evaluation

- Definition -

Page 11: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

It is important to know…

1. The extent of thrombosis (pop v. calf)?

2. Whether there is clot in the IVC?

3. Whether the patient has an asymptomatic PE

4. Whether there is a nondiagnosed malignancy?

5. If a thrombophilia is present?

Thrombolysis for DVT

Pre Op Evaluation

- Questions -

Page 12: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Thrombolysis for DVT

Pre Op Evaluation

- Initial Diagnosis -

• Venous duplex confirms diagnosis

• May be falsly positive (noncompressible)

distal to proximal outflow obstruction due

to venous hypertension

Page 13: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Thrombolysis for DVT

Pre Op Evaluation

Is There Clot in the IVC?

Is it important recognize this prior to treatment?

Page 14: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Thrombolysis for DVT

Patient Selection

- Clot in Vena Cava -

Trapped

in transit

Post CDT

Page 15: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Comerota AJ, Gale S

J Vasc Surg 2006;43:185-91.

Caval Clot

Venous Thrombectomy

Page 16: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Specimen

Venous Thrombectomy

Page 17: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Thrombolysis for DVT

Pre Op Evaluation

Is this important to diagnose?

If patient subsequently developed

pleuritic chest pain 4 days later, and PE

Dx made, then would patient be

considered a failure of anticoagulation?

Page 18: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Thrombolysis for DVT

Pre Op Evaluation

Is it important to identify an

associated, but not previously

diagnosed malignancy

Page 19: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Thrombolysis for DVT

Pre Op Evaluation

- Pre Treatment CT Scan -

Page 20: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Thrombolysis for DVT

Pre Op Evaluation

- Pre Treatment CT Scan -

Page 21: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Mediastinal Lymphadenopathy

Phlegmasia Cerulea Dolens

Page 22: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Retroperitonal and Pelvic Lymphadenopathy

Phlegmasia Cerulea Dolens

Page 23: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Thrombolysis for DVT

Pre Op Evaluation

Is it important to know if a

thrombophilia is present to

properly treat the patient?

- Thrombophilia -

NO!

The most important person affected by

a thrombophilia evaluation is a first

degree female relative of child-bearing,

estrogen taking potential

Page 24: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Thrombolysis for DVT

Patient Selection and Pre Op Evaluation

- Summary -

• Iliofemoral DVT

• Know full extent of thrombus

– IVC

– Limitations of duplex

• Diagnose a symptomatic DVT and cancer

• Thrombophilia evaluation should be delayed

Page 25: Thrombolysis for DVT · 1,149 Symptomatic DVT Rx’ed with Anticoagulation Iliofemoral DVT Overall recurrence @ 3 mos –5.1% Femoral vein thrombosis –5.3% Iliofemoral DVT –11.8%

Recommended